出典:Wikipedia
出典:『Wikipedia』 (2011/06/30 23:52 UTC 版)
Canakinumab (INN, trade name Ilaris, previously ACZ885) is a human monoclonal antibody targeted at interleukin-1 beta. It has no cross-reactivity with other members of the interleukin-1 family, including interleukin-1 alpha.